UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

Bariatric Surgery Study

Not Applicable

Conditions: Depression
Quality of Life
Interpersonal Relations

Interventions: Behavioral: Functional Analytical Psychotherapy (FAP)

First Posted Date: 2018-12-06

Last Posted Date: 2018-12-06

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT03766360

Locations: 🇺🇸
Weight Loss Management Center at UWMC-Roosevelt, Seattle, Washington, United States

Islamic Trauma Healing: Feasibility Study

Not Applicable

Completed

Conditions: Post Traumatic Stress Disorder

Interventions: Behavioral: Islamic Trauma Healing

First Posted Date: 2018-12-03

Last Posted Date: 2023-11-21

Lead Sponsor: University of Washington

Target Recruit Count: 28

Registration Number: NCT03761732

Locations: 🇸🇴
Borama Mosque, Borama, Somalia
🇸🇴
Hargeisa Mosque, Hargeisa, Somalia

Induced Gingivitis & Intra-oral Imaging

Not Applicable

Completed

Conditions: Plaque Induced Gingivitis

Interventions: Device: Plaque induced gingivitis
Device: Oral hygiene maintenance

First Posted Date: 2018-11-23

Last Posted Date: 2021-03-09

Lead Sponsor: University of Washington

Target Recruit Count: 16

Registration Number: NCT03750955

Locations: 🇺🇸
University of Washington School of Dentistry, Seattle, Washington, United States

Nivolumab and Ipilimumab and Stereotactic Body Radiation Therapy in Treating Patients With Salivary Gland Cancers

Phase 1

Completed

Conditions: Metastatic Malignant Neoplasm in the Lung
Salivary Gland Carcinoma
Stage IV Major Salivary Gland Cancer AJCC v8
Stage IVB Major Salivary Gland Cancer AJCC v8
Stage IVA Major Salivary Gland Cancer AJCC v8
Stage IVC Major Salivary Gland Cancer AJCC v8
Metastatic Malignant Neoplasm in the Bone

Interventions: Biological: Nivolumab
Biological: Ipilimumab
Radiation: Stereotactic Body Radiation Therapy

First Posted Date: 2018-11-21

Last Posted Date: 2023-12-29

Lead Sponsor: University of Washington

Target Recruit Count: 20

Registration Number: NCT03749460

Locations: 🇺🇸
Fred Hutch/University of Washington Cancer Consortium, Seattle, Washington, United States

Latina Friends Motivating the Soul (ALMA)

Not Applicable

Withdrawn

Conditions: Stress
Depression
Anxiety

Interventions: Behavioral: Latina Friends Motivating the Soul (ALMA)

First Posted Date: 2018-11-21

Last Posted Date: 2023-05-10

Lead Sponsor: University of Washington

Registration Number: NCT03749278

Locations: 🇺🇸
El Centro de la Raza, Seattle, Washington, United States
🇺🇸
Casa Latina, Seattle, Washington, United States

Project to Improve Communication About Serious Illness - Pilot Study

Not Applicable

Completed

Conditions: Leukemia, Lymphocytic, Chronic, B-Cell
Congestive Heart Failure
Dementia
Peripheral Vascular Disease
Diabetes Complications
Malignant Neoplasm
Renal Insufficiency, Chronic
Lung Disease Chronic
Liver Failures, Chronic
Frail Elderly

Interventions: Behavioral: Jumpstart Intervention

First Posted Date: 2018-11-19

Last Posted Date: 2020-11-04

Lead Sponsor: University of Washington

Target Recruit Count: 150

Registration Number: NCT03746392

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States
🇺🇸
University of Washington Medical Center, Seattle, Washington, United States

Strategies to Improve Pain and Enjoy Life

Not Applicable

Completed

Conditions: Chronic Pain

Interventions: Behavioral: Pain self-management training
Other: usual care
Behavioral: video education, motivational interviewing
Behavioral: voluntary self-paced opioid taper
Behavioral: prescribing guidance for primary care provider

First Posted Date: 2018-11-16

Last Posted Date: 2023-04-07

Lead Sponsor: University of Washington

Target Recruit Count: 153

Registration Number: NCT03743402

Locations: 🇺🇸
Kaiser Permanente Washington, Seattle, Washington, United States

Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Phase 2

Recruiting

Conditions: Acute Myeloid Leukemia

Interventions: Drug: Gemtuzumab Ozogamicin
Other: Quality-of-Life Assessment

First Posted Date: 2018-11-13

Last Posted Date: 2024-07-01

Lead Sponsor: University of Washington

Target Recruit Count: 36

Registration Number: NCT03737955

Locations: 🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Multiparametric MRI for Assessing Breast Cancer Response to Anti-HER2 Therapy

Active, not recruiting

Conditions: HER2-positive Breast Cancer

First Posted Date: 2018-11-13

Last Posted Date: 2024-07-09

Lead Sponsor: University of Washington

Target Recruit Count: 13

Registration Number: NCT03738553

Locations: 🇺🇸
Seattle Cancer Care Alliance, Seattle, Washington, United States

Increasing Enteral Protein Intake in Critically Ill Trauma and Surgical Patients

Not Applicable

Completed

Conditions: Critical Illness
Malnutrition
Enteral Nutrition
Protein Supplementation

Interventions: Dietary Supplement: Modular enteral protein - Prosource

First Posted Date: 2018-11-07

Last Posted Date: 2018-11-07

Lead Sponsor: University of Washington

Target Recruit Count: 118

Registration Number: NCT03733782

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy